肿瘤纤维化与胰腺腺癌患者生存相关,并可通过临床影像学特征预测
该研究纳入131例接受一线手术的胰腺腺癌患者,评估肿瘤纤维化的预后价值,并将全队列随机分为训练集(n=88)和验证集(n=43),用二元逻辑回归筛选纤维化的独立危险因素并构建列线图。纤维化与较差的总生存和无病生存相关,列线图在训练集和验证集的AUC分别为0.810和0.804,校准曲线和决策曲线分析显示良好。
要点
- 肿瘤纤维化与胰腺腺癌患者较差的总生存和无病生存相关。
- 纤维化可依据其与总生存和无病生存的关联进行分级,40%为约登切点。
- 包含CA19-9、肿瘤直径和胰周浸润的列线图可用于术前预测肿瘤纤维化。
核心结论
- 肿瘤纤维化与胰腺腺癌患者较差的总生存和无病生存相关,包含临床影像学特征的列线图有助于术前预测肿瘤纤维化。
研究设计与样本
- 研究纳入131例接受一线手术的胰腺腺癌患者,全队列随机分为训练集(n=88)和验证集(n=43),采用Cox回归和ROC分析确定纤维化的预后价值及切点,在训练集中用二元逻辑回归筛选独立危险因素并构建列线图,用校准曲线和决策曲线分析评估列线图性能。
诊断标准与关键数值
- 纤维化对总生存的风险比为1.121(95%CI:1.082-1.161),对无病生存的风险比为1.110(95%CI:1.067-1.155);ROC分析确定40%为总生存和无病生存的约登切点纤维化点;列线图的曲线下面积在训练集为0.810、在验证集为0.804;肿瘤直径、碳水化合物抗原19-9水平和胰周肿瘤浸润为独立危险因素。
临床应用与阅片要点
- 作者认为,包含碳水化合物抗原19-9水平、肿瘤直径和胰周肿瘤浸润的列线图有助于术前预测肿瘤纤维化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the prognostic value of fibrosis for patients with pancreatic adenocarcinoma (PDAC) and preoperatively predict fibrosis using clinicoradiological features. Tumor fibrosis plays an important role in the chemoresistance of PDAC. However, the prognostic value of tumor fibrosis remains contradiction and accurate prediction of tumor fibrosis is required.
METHODS: The study included 131 patients with PDAC who underwent first-line surgery. The prognostic value of fibrosis and rounded cutoff fibrosis points for median overall survival (OS) and disease-free survival (DFS) were determined using Cox regression and receiver operating characteristic (ROC) analyses. Then the whole cohort was randomly divided into training (n = 88) and validation (n = 43) sets. Binary logistic regression analysis was performed to select independent risk factors for fibrosis in the training set, and a nomogram was constructed. Nomogram performance was assessed using a calibration curve and decision curve analysis (DCA).
RESULTS: Hazard ratios of fibrosis for OS and DFS were 1.121 (95% confidence interval [CI]: 1.082-1.161) and 1.110 (95% CI: 1.067-1.155). ROC analysis identified 40% as the rounded cutoff fibrosis point for median OS and DFS. Tumor diameter, carbohydrate antigen 19-9 level, and peripancreatic tumor infiltration were independent risk factors; areas under the nomogram curve were 0.810 and 0.804 in the training and validation sets, respectively. The calibration curve indicated good agreement of the nomogram, and DCA demonstrated good clinical usefulness.
CONCLUSIONS: Tumor fibrosis was associated with poor OS and DFS in patients with PDAC. The nomogram incorporating clinicoradiological features was useful for preoperatively predicting tumor fibrosis.
KEY POINTS: • Tumor fibrosis is correlated with poor prognosis in patients with pancreatic adenocarcinoma. • Tumor fibrosis can be categorized according to its association with overall survival and disease-free survival. • A nomogram incorporating carbohydrate antigen 19-9 level, tumor diameter, and peripancreatic tumor infiltration is useful for preoperatively predicting tumor fibrosis.
引用
- Shi, Luo, Wang, et al. Tumor fibrosis correlates with the survival of patients with pancreatic adenocarcinoma and is predictable using clinicoradiological features. Eur Radiol. 2022. PMID: 35420301. doi:10.1007/s00330-022-08745-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。